580.28MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04335A1051
CUSIP
04335A105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
9.04
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.66
Wall Street Target Price
19.36
EPS Estimate Current Year
-1.43
EPS Estimate Next Year
-3.48
EPS Estimate Current Quarter
-0.9697
EPS Estimate Next Quarter
-1.0101
Most Recent Quarter
-
Revenue TTM
426,900,000
Gross Profit TTM
426,900,000
EBITDA
-91,400,000
Profit Margin
-10.92%
Return On Assets TTM
-5.39%
Return On Equity TTM
-7.34%
Revenue Per Share TTM
5.921
Qtly Revenue Growth YOY
646.20%
Diluted Eps TTM
-0.66
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
17
Price Sales TTM
1.3593
Price Book MRQ
0.8791
Enterprise Value Revenue
5
Enterprise Value EBITDA
-1
152.73
1.13%79.96
0.99%331.91
0.72%459.27
0.51%245.00
0.34%547.60
0.00%96.19
-2.12%543.48
-0.62%546.11
-0.28%199.84
-0.03%